Form 4: Septerna Inc. Director Ezekowitz Granted Stock Options

Septerna, Inc. director Alan Ezekowitz was granted 15,000 stock options with an exercise price of $37.34, vesting in full by June 26, 2027 or the next annual meeting.

Summary

• Alan Ezekowitz, a Director at Septerna, Inc., was granted 15,000 stock options on June 26, 2026.
• The stock options have an exercise price of $37.34 per share.
• These options are set to vest in full on the earlier of June 26, 2027, or the date of the Issuer's next annual meeting of stockholders.
• Vesting is contingent upon Ezekowitz's continued service to the Issuer through the vesting date.
• The filing also includes a Substitute Power of Attorney appointing Gil M. Labrucherie and Mark A. Wilson as substitute attorneys-in-fact for several individuals, including Alan Ezekowitz, to execute SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily details a standard stock option grant to a director and a procedural power of attorney, without significant new financial or strategic information.

Positives

• Grant of stock options to a director, indicating potential alignment of management and shareholder interests.
• The stock options have a clear exercise price and vesting schedule, providing transparency.

Risks

• The vesting of stock options is contingent on continued service, meaning departure from the company before the vesting date would result in forfeiture.
• The exercise price of $37.34 implies a certain valuation expectation for Septerna, Inc. stock.

Future Outlook

The stock options granted to Alan Ezekowitz will vest in full on the earlier of June 26, 2027, or the date of Septerna, Inc.'s next annual meeting of stockholders, provided he remains in service to the Issuer through that date. The options expire on June 25, 2036.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, like Septerna, Inc., to incentivize long-term performance and align executive interests with those of shareholders. The specific exercise price and vesting schedule are typical for such grants.

Corporate Governance

Related Party Transactions

• Grant of 15,000 stock options to Director Alan Ezekowitz.

Stakeholder Impact

• Shareholders: The stock option grant aligns director incentives with potential future stock price appreciation, but also represents potential dilution if exercised.
• Employees: The filing does not directly impact employees, but the underlying company performance that influences stock price is relevant.
• Management: The power of attorney filing streamlines compliance for management and directors.

Next Steps

• Alan Ezekowitz must continue his service to Septerna, Inc. through the vesting date for the stock options to vest.
• The stock options will become exercisable on the vesting date.
• The Substitute Power of Attorney remains in effect until revoked or terminated.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, Director Compensation, Septerna Inc., SEPN, Beneficial Ownership, Insider Trading, Vesting Schedule, Power of Attorney